Abstract
To verify some animal experimental results in humans, we have studied urinary epidermal growth factor (EGF) excretion in normal children as well as children with acute renal failure (ARF). Urinary EGF excretion was expressed as a ratio of urinary EGF to urinary creatinine concentration (EGF/Cr) for random and 24-h urine, and a daily total urinary EGF for 24-h urine. The highest urinary EGF/Cr in children was found at 1 mo to 3 y of age. There was a highly significant correlation between random urine EGF/Cr and 24-h urine EGF/Cr (r = 0.92, p < 0.001), whereas no correlation of urinary EGF/Cr with daily total urine EGF was found. During the course of ARF, a decline in urinary EGF/Cr from the period before peak serum creatinine to the period after the declination of serum creatinine was noted (p = 0.013, n = 13, by repeated measure analysis), with a constant low daily total urine EGF (p value not significant). However, a rise in both urinary EGF/Cr and daily total urine EGF was found between the period of serum creatinine decline and the period of completely normal serum creatinine(p < 0.001). Serum EGF remained unchanged throughout the course of ARF. These results suggest 1) the possible role of EGF in renal growth or maturation during the first 2 or 3 y of life, 2) the possible renal origin of human urinary EGF, and 3) decreased urinary EGF excretion in children with ARF. In particular, EGF/Cr is not a reliable indicator for the expression of actual urinary EGF excretion in ARF. Instead of urinary EGF/Cr, urinary EGF concentration may be used to predict the daily total urinary EGF excretion during ARF. These results provide the pattern of urinary EGF excretion during ARF in children and may be of help for further clinical studies.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- ARF:
-
acute renal failure
- EGF:
-
epidermal growth factor
- EGF/Cr,:
-
ratio of EGF to creatinine
References
Norman J, Badie-Dezfooly B, Nord EP, Kurtz I, Schlosser J, Chaudhari A, Fine LG 1987 EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 253:F299–F309
Mattila A-L, Perheentupa J, Pesonen K, Viinikka L 1985 Epidermal growth factor in human urine from birth to puberty. J Clin Endocrinol Metab 61: 997–1000
Perheentupa J, Lakshmanan J, Fisher DA 1985 Urine and kidney epidermal growth factor: ontogeny and sex difference in the mouse. Pediatr Res 19: 428–432
Rall LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD, Coghlan JP 1985 Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 313: 228–231
Safirstein R, Zelent AZ, Price PM 1989 Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARF. Kidney Int 36: 810–815
Safirstein R, Price PM, Saggi SJ, Harris RC 1990 Changes in gene expression after temporary renal ischemia. Kidney Int 37: 1515–1521
Norman J, Tsau YK, Bacay A, Fine LG 1990 Epidermal growth factor accelerates functional recovery from ischemic acute tubular necrosis in the rat: role of the epidermal growth factor receptor. Clin Sci 78: 445–450
Feld LG, Springate JE, Fildes RD 1986 Acute renal failure: I. pathophysiology and diagnosis. J Pediatr 109: 401–408
Zeger SL, Liang KY, Albert PS 1988 Models for longitudinal data: a generalized estimating equation approach. Biometrics 44: 1049–1060
Callegari C, Laborde NP, Buenaflor G, Nascimento CG, Brasel JA, Fisher DA 1988 The source of urinary epidermal growth factor in humans. Eur J Appl Physiol 58: 26–31
Mattila A-L, Pasternack A, Viinikka L, Perheentupa J 1986 Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease. J Clin Endocrinol Metab 62: 1180–1183
Watanabe K, Ono A, Hirata Y, Fukuda Y, Kojima T, Kobayashi Y 1989 Maturational changes and origin of urinary human epidermal growth factor in the neonatal period. Biol Neonate 56: 241–245
Scott SM, Guardian CM, Angelus P, Backstrom C 1991 Developmental pattern of urinary epidermal growth factor in the premature infant and the influence of gender. J Clin Endocrinol Metab 72: 588–593
Scott SM, Guardian C, Rogers C, Angelus P, Werner S 1989 Effect of congenital renal disease and neonatal thyroid status on urinary human epidermal growth factor concentrations. Acta Endocrinol 121: 505–512
Fisher DA, Salido EC, Barajas L 1989 Epidermal growth factor and the kidney. Annu Rev Physiol 51: 67–80
Harris RC 1991 Potential physiologic roles for epidermal growth factor in the kidney. Am J Kidney Dis 17: 627–630
Hamm LL, Hering-Smith KS, Vehaskari VM 1993 Epidermal growth factor and the kidney. Semin Nephrol 13: 109–115
Gattone VH, Sherman DA, Hinton DA, Niu FW, Topham RT, Klein RM 1992 Epidermal growth factor in the neonatal mouse salivary gland and kidney. Biol Neonate 61: 54–67
Rubin MI, Bruck E, Rapoport M 1949 Maturation of renal function in childhood: clearance studies. J Clin Invest 28: 1144–1162
Tsau YK, Chen CH, Teng RJ, Tsai WS, Sheu JN 1991 UrinaryN-acetyl-β-glucosaminidase in normal Chinese children and children with pyelonephritis. Acta Paediatr Sin 32: 24–30
Liao MH, Tsau YK, Chu JM 1993 Using quantitative ultrasound to estimate renal maturation. Acta Paediatr Sin 34: 367–371
Taira T, Yoshimura A, Ideura T, Koshikawa S 1992 Clinical significance of urinary epidermal growth factor levels in patients with acute renal failure. Nephron 60: 375
Lev-Ran A, Hwang DL, Ben-Ezra J, Williams LE 1992 Origin of urinary epidermal growth factor in humans: excretion of endogenous EGF and infused 131I-human EGF and kidney histochemistry. Clin Exp Pharmacol Physiol 19: 667–673
Salido EC, Yen PH, Shapiro LJ, Fisher DA, Barajas L 1989 In situ hybridization of prepro-epidermal growth factor mRNA in the mouse kidney. Am J Physiol 256:F632–F638
Schaudies RP, Johnson JP 1993 Increased soluble EGF after ischemia is accompanied by a decrease in membrane-associated precursors. Am J Physiol 264:F523–F531
Humes HD, Cieslinski DA, Coimbra TM, Messana JM, Galvao C 1989 Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest 84: 1757–1761
Author information
Authors and Affiliations
Additional information
Supported by a grant from the National Science Council of the Republic of China (NSC-81-0412-B002-625).
Rights and permissions
About this article
Cite this article
Tsau, YK., Sheu, JN., Chen, CH. et al. Decreased Urinary Epidermal Growth Factor in Children with Acute Renal Failure: Epidermal Growth Factor/Creatinine Ratio Not a Reliable Parameter for Urinary Epidermal Growth Factor Excretion. Pediatr Res 39, 20–24 (1996). https://doi.org/10.1203/00006450-199601000-00003
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199601000-00003
This article is cited by
-
A novel urinary biomarker profile to identify acute kidney injury (AKI) in critically ill neonates: a pilot study
Pediatric Nephrology (2013)
-
A pilot study of urinary fibroblast growth factor-2 and epithelial growth factor as potential biomarkers of acute kidney injury in critically ill children
Pediatric Nephrology (2013)
-
Effect of asphyxia on urinary epidermal growth factor levels in newborns
Journal of Tongji Medical University (1997)
